Diabetes Obes Metab

Obesity-associated metabolites in relation to type 2 diabetes risk: A prospective nested case-control study of the CARRS cohort.

Ali MK, Kadir MM, Gujral UP, ..., Narayan KMV, Ahmad S

Diabetes Obes Metab 24 (10) 2008-2016 [2022-10-00; online 2022-07-05]

Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study.

Oldgren J, Laurila S, Åkerblom A, ..., Oscarsson J, Nuutila P

Diabetes Obes Metab 23 (7) 1505-1517 [2021-07-00; online 2021-03-12]

Olof Eriksson SciLifeLab Fellow